Fresh Hilites Medicaments Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-11-2024
- Paid Up Capital ₹ 0.10 M
as on 03-11-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 03-11-2024
- Revenue -9.65%
(FY 2023)
- Profit -6.72%
(FY 2023)
- Ebitda -6.72%
(FY 2023)
- Net Worth 83.84%
(FY 2023)
- Total Assets 146.19%
(FY 2023)
About Fresh Hilites Medicaments
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Manojkumar Nandanwar, Pooja Zambad, and Shailesh Zambad serve as directors at the Company.
- CIN/LLPIN
U33119MH2020PTC347271
- Company No.
347271
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 2020
- Date of AGM
14 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Fresh Hilites Medicaments?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manojkumar Nandanwar  | Director | 06-Oct-2020 | Current |
| Pooja Zambad | Director | 06-Oct-2020 | Current |
| Shailesh Zambad | Director | 05-Jun-2023 | Current |
Financial Performance of Fresh Hilites Medicaments.
Fresh Hilites Medicaments Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.65% decrease. The company also saw a slight decrease in profitability, with a 6.72% decrease in profit. The company's net worth Soared by an impressive increase of 83.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fresh Hilites Medicaments?
Unlock access to Fresh Hilites Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Jan 2023 | ₹2.00 Cr | Open |
How Many Employees Work at Fresh Hilites Medicaments?
Fresh Hilites Medicaments has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fresh Hilites Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fresh Hilites Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
